Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Foss

Showing results (201-210 of 258) with videos related to

Pageof 26
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 21, 2020
Endovascular Therapy or Alteplase in Patients with Comorbidities: Insights from UNMASK EVTAravind Ganesh, Nima Kashani, Johanna M Ospel, et al.
The Journal of Investigative Dermatology|June 15, 2020
Screening Novel Agent Combinations to Expedite CTCL Therapeutic DevelopmentFatima N Mirza, Sara Yumeen, Julia M Lewis, et al.
Blood Advances|May 22, 2020
JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCLSara Yumeen, Fatima N Mirza, Julia M Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, D L Breneman, et al.
Infectious Disease Modelling|October 26, 2020
Using data from 'visible' populations to estimate the size and importance of 'hidden' populations in an epidemic: A modelling techniqueAnna M Foss, Holly J Prudden, Kate M Mitchell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, I R Linnoila, et al.
Environment International|June 24, 2025
Regional variations in the impacts of high temperature on hospital admissions in BrazilHuiqi Chen, Ivan Augusto Cecilio E Silva, Shakoor Hajat, et al.
The New England Journal of Medicine|December 28, 1989
A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoidesF J Kaye, P A Bunn, S M Steinberg, et al.
Journal of the American Board of Family Medicine : JABFM|February 20, 2025
Relationship Between Social Risks and Diabetes Metrics in a US Health SystemJessica L Sosso, Karen M Fischer, Michelle A Lampman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphomaElise A Olsen, Youn H Kim, Timothy M Kuzel, et al.
Pageof 26

Showing results (201-210 of 258) with videos related to

Sort By:
Pageof 26
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 21, 2020
Endovascular Therapy or Alteplase in Patients with Comorbidities: Insights from UNMASK EVTAravind Ganesh, Nima Kashani, Johanna M Ospel, et al.
The Journal of Investigative Dermatology|June 15, 2020
Screening Novel Agent Combinations to Expedite CTCL Therapeutic DevelopmentFatima N Mirza, Sara Yumeen, Julia M Lewis, et al.
Blood Advances|May 22, 2020
JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCLSara Yumeen, Fatima N Mirza, Julia M Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, D L Breneman, et al.
Infectious Disease Modelling|October 26, 2020
Using data from 'visible' populations to estimate the size and importance of 'hidden' populations in an epidemic: A modelling techniqueAnna M Foss, Holly J Prudden, Kate M Mitchell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, I R Linnoila, et al.
Environment International|June 24, 2025
Regional variations in the impacts of high temperature on hospital admissions in BrazilHuiqi Chen, Ivan Augusto Cecilio E Silva, Shakoor Hajat, et al.
The New England Journal of Medicine|December 28, 1989
A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoidesF J Kaye, P A Bunn, S M Steinberg, et al.
Journal of the American Board of Family Medicine : JABFM|February 20, 2025
Relationship Between Social Risks and Diabetes Metrics in a US Health SystemJessica L Sosso, Karen M Fischer, Michelle A Lampman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphomaElise A Olsen, Youn H Kim, Timothy M Kuzel, et al.
Pageof 26